 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Investigational Immunotherapy Treatments Offering Promise in Treating Pancreatic Cancer as Risk Factors Rise Investigational Immunotherapy Treatments Offering Promise in Treating Pancreatic Cancer as...

Investigational Immunotherapy Treatments Offering Promise in Treating Pancreatic Cancer as Risk Factors Rise

THE PANCREATIC CANCER ACTION NETWORK SELECTS ONCOLYTICS BIOTECH INC. TO RECEIVE $5 MILLION THERAPEUTIC ACCELERATOR AWARD TO DEVELOP LEADING-EDGE TREATMENTS THE PANCREATIC CANCER ACTION NETWORK...

THE PANCREATIC CANCER ACTION NETWORK SELECTS ONCOLYTICS BIOTECH INC. TO RECEIVE $5 MILLION THERAPEUTIC ACCELERATOR AWARD TO DEVELOP LEADING-EDGE TREATMENTS

Pancreatic Cancer Research Gains Momentum Amidst Soaring Young-Onset Cases Pancreatic Cancer Research Gains Momentum Amidst Soaring Young-Onset Cases PR Newswire VANCOUVER, British Columbia, Sept...

Pancreatic Cancer Research Gains Momentum Amidst Soaring Young-Onset Cases

Revolutionary Cancer Treatment Advances Promise Brighter Future Amid Federal Funding Uncertainty Revolutionary Cancer Treatment Advances Promise Brighter Future Amid Federal Funding Uncertainty PR...

Revolutionary Cancer Treatment Advances Promise Brighter Future Amid Federal Funding Uncertainty

On the Road to Halving Cancer: The 2023 Biotech Advancements Igniting Hope On the Road to Halving Cancer: The 2023 Biotech Advancements Igniting Hope PR Newswire VANCOUVER, British Columbia, Sept...

On the Road to Halving Cancer: The 2023 Biotech Advancements Igniting Hope

Oncolytics Biotech Announces Fireside Chat at the Cantor Global Healthcare Conference Oncolytics Biotech Announces Fireside Chat at the Cantor Global Healthcare Conference PR Newswire SAN DIEGO and...

Oncolytics Biotech Announces Fireside Chat at the Cantor Global Healthcare Conference

Oncolytics Biotech Announces Fireside Chat at the Cantor Global Healthcare Conference Oncolytics Biotech Announces Fireside Chat at the Cantor Global Healthcare Conference Canada NewsWire SAN DIEGO...

Pancreatic Cancer Battle Boosted by $200M VC Firm Pancreatic Cancer Battle Boosted by $200M VC Firm PR Newswire VANCOUVER, BC, Sept. 19, 2023 FN Media Group Presents USA News Group News Commentary...

Pancreatic Cancer Battle Boosted by $200M VC Firm

Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus that induce selective tumor lysis, and promotes an inflamed tumor phenotype through innate and adaptive immune responses. The company was founded by Matthew C. Coffey and Bradley George Thompson on April 2, 1998 and is headquartered in Calgary, Canada.

Watchers	7,042
52-Wk Low	$1.09
52-Wk High	$3.39

Market Cap	$151.25M
Volume (M)	366,638.00
52-Wk High	$3.39
52-Wk Low	$1.09

ONCY Oncolytics Biotech, Inc.

About

Feed

News

Earnings

Fundamentals